Birdwatch Note
2024-11-21 06:09:05 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The vaccine developed by Moderna in 2017 was mRNA-1440, an mRNA vaccine against avian influenza H10N8, NOT Covid. https://pubmed.ncbi.nlm.nih.gov/31079849/ https://pmc.ncbi.nlm.nih.gov/articles/PMC5475249/ https://investors.modernatx.com/news/news-details/2017/Moderna-Announces-Positive-Interim-Phase-1-Clinical-Data-Demonstrating-First-mRNA-Vaccine-Candidate-mRNA-1440-Induces-High-Levels-of-Immunogenicity/default.aspx
Written by 77D163A62EC00F50DD4CB85110FCF791EAB9AE938196E73975820E81A5482496
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1859460979341341110
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1859479125217489167
- noteId - 1859479125217489167
- participantId -
- noteAuthorParticipantId - 77D163A62EC00F50DD4CB85110FCF791EAB9AE938196E73975820E81A5482496 Participant Details
- createdAtMillis - 1732169345560
- tweetId - 1859460979341341110
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The vaccine developed by Moderna in 2017 was mRNA-1440, an mRNA vaccine against avian influenza H10N8, NOT Covid. https://pubmed.ncbi.nlm.nih.gov/31079849/ https://pmc.ncbi.nlm.nih.gov/articles/PMC5475249/ https://investors.modernatx.com/news/news-details/2017/Moderna-Announces-Positive-Interim-Phase-1-Clinical-Data-Demonstrating-First-mRNA-Vaccine-Candidate-mRNA-1440-Induces-High-Levels-of-Immunogenicity/default.aspx
Note Ratings
| rated at | rated by | |
| 2024-11-21 21:32:21 -0600 | Rating Details | |
| 2024-11-21 08:38:31 -0600 | Rating Details | |
| 2024-11-21 07:56:41 -0600 | Rating Details | |
| 2024-11-21 07:26:52 -0600 | Rating Details | |
| 2024-11-21 07:14:02 -0600 | Rating Details | |
| 2024-11-21 07:12:15 -0600 | Rating Details | |
| 2024-11-21 06:35:05 -0600 | Rating Details | |
| 2024-11-21 06:33:13 -0600 | Rating Details | |
| 2024-11-21 06:01:57 -0600 | Rating Details | |
| 2024-11-21 05:39:57 -0600 | Rating Details | |
| 2024-11-21 05:36:44 -0600 | Rating Details | |
| 2024-11-21 05:12:30 -0600 | Rating Details | |
| 2024-11-21 04:47:44 -0600 | Rating Details | |
| 2024-11-21 04:41:07 -0600 | Rating Details | |
| 2024-11-21 04:22:26 -0600 | Rating Details | |
| 2024-11-21 03:34:12 -0600 | Rating Details | |
| 2024-11-21 03:16:27 -0600 | Rating Details | |
| 2024-11-21 03:11:13 -0600 | Rating Details | |
| 2024-11-21 03:08:25 -0600 | Rating Details | |
| 2024-11-21 02:55:25 -0600 | Rating Details | |
| 2024-11-21 02:35:24 -0600 | Rating Details | |
| 2024-11-21 02:17:23 -0600 | Rating Details | |
| 2024-11-21 02:15:16 -0600 | Rating Details | |
| 2024-11-21 02:14:56 -0600 | Rating Details | |
| 2024-11-21 01:32:05 -0600 | Rating Details | |
| 2024-11-21 01:22:19 -0600 | Rating Details | |
| 2024-11-21 01:20:25 -0600 | Rating Details | |
| 2024-11-21 01:07:39 -0600 | Rating Details | |
| 2024-11-21 01:05:58 -0600 | Rating Details | |
| 2024-11-21 01:00:46 -0600 | Rating Details | |
| 2024-11-21 00:57:42 -0600 | Rating Details | |
| 2024-11-21 00:50:25 -0600 | Rating Details | |
| 2024-11-21 00:30:21 -0600 | Rating Details | |
| 2024-11-21 00:29:40 -0600 | Rating Details | |
| 2024-11-21 18:44:08 -0600 | Rating Details | |
| 2024-11-21 02:47:56 -0600 | Rating Details | |
| 2024-11-21 02:17:59 -0600 | Rating Details | |
| 2024-11-21 02:00:27 -0600 | Rating Details | |
| 2024-11-21 01:44:11 -0600 | Rating Details | |
| 2024-11-21 01:01:33 -0600 | Rating Details | |
| 2024-11-21 01:01:01 -0600 | Rating Details | |
| 2024-11-21 00:58:35 -0600 | Rating Details | |
| 2024-11-21 00:58:32 -0600 | Rating Details | |
| 2024-11-21 00:51:12 -0600 | Rating Details | |
| 2024-11-21 00:43:47 -0600 | Rating Details | |
| 2024-11-21 00:15:22 -0600 | Rating Details | |
| 2024-11-24 20:02:01 -0600 | Rating Details | |
| 2024-11-22 05:55:52 -0600 | Rating Details | |
| 2024-11-21 07:06:17 -0600 | Rating Details | |
| 2024-11-21 06:37:53 -0600 | Rating Details | |
| 2024-11-21 05:47:00 -0600 | Rating Details | |
| 2024-11-21 03:24:19 -0600 | Rating Details | |
| 2024-11-21 03:17:16 -0600 | Rating Details | |
| 2024-11-21 02:33:43 -0600 | Rating Details | |
| 2024-11-21 02:17:09 -0600 | Rating Details | |
| 2024-11-21 02:01:04 -0600 | Rating Details | |
| 2024-11-21 01:32:23 -0600 | Rating Details | |
| 2024-11-21 01:17:01 -0600 | Rating Details | |
| 2024-11-21 01:06:26 -0600 | Rating Details | |
| 2024-11-21 00:47:49 -0600 | Rating Details | |
| 2024-11-21 00:35:36 -0600 | Rating Details | |
| 2024-11-21 00:20:59 -0600 | Rating Details | |
| 2024-11-21 11:34:50 -0600 | Rating Details | |
| 2024-11-21 08:59:21 -0600 | Rating Details | |
| 2024-11-21 07:36:12 -0600 | Rating Details | |
| 2024-11-21 06:54:32 -0600 | Rating Details | |
| 2024-11-21 03:17:59 -0600 | Rating Details | |
| 2024-11-21 02:19:47 -0600 | Rating Details | |
| 2024-11-21 02:14:20 -0600 | Rating Details | |
| 2024-11-21 00:46:59 -0600 | Rating Details |